New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?

Several clinical trials attempted to identify novel treatment options for advanced gastroesophageal tumours in first, second and further lines. Although results of targeted therapy regimens were mainly disappointing, novel immunotherapy agents showed promising activity, which led to their approval i...

Descripción completa

Detalles Bibliográficos
Autores principales: Puhr, Hannah Christina, Preusser, Matthias, Prager, Gerald, Ilhan-Mutlu, Aysegül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072704/
https://www.ncbi.nlm.nih.gov/pubmed/32012895
http://dx.doi.org/10.3390/cancers12020301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072704/
https://www.ncbi.nlm.nih.gov/pubmed/32012895
http://dx.doi.org/10.3390/cancers12020301

Ejemplares similares